title: The anti-tumor drug bleomycin preferentially cleaves at the transcription start sites of actively transcribed genes in human cells.
abstract: The genome-wide pattern of DNA cleavage at transcription start sites (TSSs) for the anti-tumor drug bleomycin was examined in human HeLa cells using next-generation DNA sequencing. It was found that actively transcribed genes were preferentially cleaved compared with non-transcribed genes. The 143,600 identified human TSSs were split into non-transcribed genes (82,596) and transcribed genes (61,004) for HeLa cells. These transcribed genes were further split into quintiles of 12,201 genes comprising the top 20, 20-40, 40-60, 60-80, and 80-100 % of expressed genes. The bleomycin cleavage pattern at highly transcribed gene TSSs was greatly enhanced compared with purified DNA and non-transcribed gene TSSs. The top 20 and 20-40 % quintiles had a very similar enhanced cleavage pattern, the 40-60 % quintile was intermediate, while the 60-80 and 80-100 % quintiles were close to the non-transcribed and purified DNA profiles. The pattern of bleomycin enhanced cleavage had peaks that were approximately 200 bp apart, and this indicated that bleomycin was identifying the presence of phased nucleosomes at TSSs. Hence bleomycin can be utilized to detect chromatin structures that are present at actively transcribed genes. In this study, for the first time, the pattern of DNA damage by a clinically utilized cancer chemotherapeutic agent was performed on a human genome-wide scale at the nucleotide level.
authors: School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, NSW, 2052, Australia, v.murray@unsw.edu.au.
authors: Vincent
authors: V
authors: Murray
authors: Jon K
authors: JK
authors: Chen
authors: Anne M
authors: AM
authors: Galea
mesh_terms: D001761:Bleomycin / Q000494:pharmacology*; D053837:DNA Cleavage / Q000187:drug effects*; D004249:DNA Damage / Q000187:drug effects / Q000235:genetics; D005796:Genes / Q000187:drug effects / Q000235:genetics*; D006367:HeLa Cells; D059014:High-Throughput Nucleotide Sequencing; D006801:Humans; D009707:Nucleosomes / Q000378:metabolism*; D024363:Transcription Initiation Site / Q000187:drug effects*
chemical_list: D009707:Nucleosomes; D001761:Bleomycin
references: Proc Natl Acad Sci U S A. 1978 Dec;75(12):5983-7
references: 83650
references: Cancer Gene Ther. 2010 Aug;17(8):571-8
references: 20414325
references: Cancer Surv. 1986;5(1):81-91
references: 2439200
references: Nat Rev Cancer. 2005 Feb;5(2):102-12
references: 15685195
references: Cancer Res. 1981 Jun;41(6):2439-43
references: 6165462
references: J Am Chem Soc. 2012 Oct 31;134(43):17842-5
references: 23072568
references: Methods Enzymol. 2012;513:297-313
references: 22929775
references: Curr Opin Genet Dev. 2009 Apr;19(2):127-34
references: 19299119
references: Mol Cell. 2003 Jun;11(6):1587-98
references: 12820971
references: J Am Chem Soc. 2010 Dec 1;132(47):16987-96
references: 21047076
references: Chem Rev. 1998 May 7;98(3):1153-1170
references: 11848928
references: PLoS One. 2012;7(2):e32095
references: 22393380
references: Genome Biol. 2009;10(3):R25
references: 19261174
references: J Biol Chem. 1985 Sep 5;260(19):10389-91
references: 2411722
references: Genome Biol. 2009;10(10):R109
references: 19814794
references: Int J Biochem Cell Biol. 2000 Jul;32(7):695-702
references: 10856700
references: Proc Natl Acad Sci U S A. 2002 Apr 2;99(7):4592-5
references: 11904381
references: Annu Rev Genomics Hum Genet. 2008;9:387-402
references: 18576944
references: Nature. 1978 Jan 5;271(5640):83-4
references: 75507
references: Genome Res. 2013 Feb;23(2):341-51
references: 23193179
references: J Clin Oncol. 1994 Mar;12(3):644-5
references: 7509855
references: J Biol Chem. 1981 Aug 25;256(16):8608-15
references: 6167580
references: Proc Natl Acad Sci U S A. 1978 Aug;75(8):3608-12
references: 80799
references: Genome Res. 2006 Jan;16(1):123-31
references: 16344561
references: Biomaterials. 2012 Jun;33(19):4907-16
references: 22484049
references: Chem Biol Drug Des. 2010 Jun;75(6):578-89
references: 20565475
references: Int J Biochem Cell Biol. 2001 Dec;33(12):1183-92
references: 11606254
references: J Am Chem Soc. 2009 Feb 11;131(5):2013-22
references: 19146404
references: J Biol Inorg Chem. 2012 Dec;17(8):1209-15
references: 22961398
references: Biochemistry. 1981 Dec 22;20(26):7599-606
references: 6173064
references: Biochim Biophys Acta. 2004 May 25;1678(2-3):126-34
references: 15157738
references: J Biol Inorg Chem. 2012 Jan;17(1):1-9
references: 21761251
references: Nature. 2008 Nov 6;456(7218):53-9
references: 18987734
references: Antimicrob Agents Chemother. 1985 Apr;27(4):460-7
references: 2408562
references: J Biol Chem. 1988 Sep 15;263(26):12854-9
references: 2458336
references: Nature. 2005 Aug 11;436(7052):876-80
references: 15988478
references: J Biol Chem. 1980 Dec 25;255(24):11832-8
references: 6160153
references: Cell. 2008 Mar 7;132(5):887-98
references: 18329373
references: Nucleic Acids Res. 1985 Mar 11;13(5):1467-81
references: 2582361
references: Curr Opin Genet Dev. 2012 Feb;22(1):3-9
references: 22386266
references: Bioinformatics. 2009 Aug 15;25(16):2078-9
references: 19505943
references: Biochemistry. 1996 Jul 2;35(26):8753-60
references: 8679639
references: Nucleic Acids Res. 1987 Aug 25;15(16):6315-29
references: 2442726
references: Int J Biochem Cell Biol. 2005 Mar;37(3):665-78
references: 15618023
references: J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Jan 15;913-914:113-22
references: 23277328
references: Nat Biotechnol. 2007 Feb;25(2):244-8
references: 17220878
references: Nat Rev Genet. 2009 Mar;10(3):161-72
references: 19204718
references: J Antibiot (Tokyo). 1966 Sep;19(5):200-9
references: 5953301
references: J Am Chem Soc. 2013 Feb 27;135(8):2883-6
references: 23379863
references: Nucleic Acids Res. 2013 Apr;41(7):e87
references: 23413004
references: Cell Rep. 2012 Nov 29;2(5):1411-24
references: 23177624
references: Cell. 2008 Jan 25;132(2):311-22
references: 18243105